https://a7-satta.com

• Нравится 0
• Комментировать 0
• 0

Пока нет комментариев

https://babachart.com

• Нравится 0
• Комментировать 0
• 0

Пока нет комментариев

Roots Analysis has done a detailed study on “Medical Device Coatings and Surface Modification TechnologiesMarket, 2023-2035”, covering key aspects of the industry's evolution and identifying potential future growth opportunitiesKey Market Insights §Currently, more than 85 companies provide coatings that serve a wide array of functions and are compatible with a diverse array of substrate materials; majority of such players have entered this domain post 2,000§Companies engaged in this industry provide a wide range of coating materials for different types of medical devices; of these, close to 70% of the coatings are being offered for medical implants§In order to gain an edge in this competitive industry, coating providers are continuously undertaking initiatives to upgrade their existing material offerings and coating solutions for medical devices§Presently, more than 115 surface modification technologies and coating solutions are being offered by players to enhance the surface functions and resistance of medical devices§The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of the players are based in the US§In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of coatings / technologies and comply with evolving industry needs§The rising interest of stakeholders in surface modification of medical devices and coating solutions is reflected by the increasing number of partnerships established between various industry and non-industry players§Built on our intellectual capital, we have proposed a proprietary framework that can be applied to strengthen the strategic planning processes and risk management within the industry§With the rising demand for medical device coating solutions and services, the affiliated market for service providers is expected to grow at a steady annualized rate of 7.7% over the coming decade§The opportunity associated with the medical device coatings market is expected to be well distributed among players of different company sizes, with the majority of the revenue being coming in from developed regions.Table of Contents1. PREFACE 1.1. Scope of the report1.2. Market Segmentation1.3. Research Methodology1.4. Key Questions Answered1.5. Chapter Outlines2. EXECUTIVE SUMMARY3. INTRODUCTION3.1. Chapter Overview3.2. Medical Device Coatings3.2.1. Types of Medical Device Coatings3.2.2. Lubricious Coatings3.2.3. Antimicrobial Coatings3.2.4. Hydrophilic Coatings3.2.5. Advantages and Disadvantages of Medical Device Coatings3.3. Surface Modification Technologies3.3.1. Types of Surface Modification Technologies3.3.2. Advantages and Disadvantages of Surface Modification Technologies3.4. Future Perspectives 4. MEDICAL DEVICE COATING PROVIDERS: MARKET LANDSCAPE4.1. Chapter Overview4.2. Medical Device Coatings Providers: Overall Market Landscape4.2.1. Analysis by Year of Establishment4.2.2. Analysis by Company Size4.2.3. Analysis by Location of Headquarters4.2.4. Analysis by Type of Company4.2.5. Analysis by Type of Medical Device(s) Coated4.2.6. Analysis by Nature of Coating Material(s)4.2.7. Analysis by Type of Coating Material(s)4.2.8. Analysis by Type of Coating(s)4.2.9. Analysis by Type of Coating Function(s)4.2.10. Analysis by Type of Compatible Substrate(s)4.2.11. Analysis by Service(s) Offered4.2.12. Analysis by Additional Feature(s) Offered5. COMPANY COMPETITIVENESS ANALYSIS5.1. Chapter Overview5.2. Assumptions and Key Parameters5.3. methodology5.4. Medical Device Coatings Providers: Company Competitiveness Analysis5.4.1. Competitiveness Analysis: Very Small Companies5.4.2. Competitiveness Analysis: Small Companies5.4.3. Competitiveness Analysis: Mid-sized Companies5.4.4. Competitiveness Analysis: Large Companies5.4.5. Competitiveness Analysis: Very Large Companies6. SURFACE MODIFICATION TECHNOLOGIES AND COATING SOLUTIONS: MARKET LANDSCAPE6.1. Chapter Overview6.2. Surface Modification Technologies and Coating Solutions: Overall Market Landscape6.2.1. Analysis by Type of Medium(s) for Modification6.2.2. Analysis by Type of Trademark Right6.2.3. Analysis by Type of Surface Modification Process(s) Employed6.2.4. Analysis by Type of Device(s) Coated6.2.5. Analysis by Type of Medical Device(s) Coated6.2.6. Analysis by Nature of Coating Material(s)6.2.7. Analysis by Type of Coating(s) Applied6.2.8. Analysis by Type of Resistance(s) Offered6.2.9. Analysis by Type of Compatible Substrate(s)6.2.10. Analysis by Additional Feature(s) Offered6.3. Medical Device Surface Modification Technologies and Coating Solutions: Developer Landscape6.3.1. Analysis by Year of Establishment6.3.2. Analysis by Company Size6.3.3. Analysis by Location of Headquarters6.3.4. Most Active Players: Analysis by Number of Products Offered7. PRODUCT COMPETITIVENESS ANALYSIS7.1. Chapter Overview7.2. Assumptions and Key Parameters7.3. methodology7.4. Product Competitiveness Analysis7.4.1. Product Competitiveness Analysis: Technologies7.4.1.1. Technologies Developed by Very Small and Small Companies7.4.1.2. Technologies Developed by Mid-sized Companies7.4.1.3. Technologies Developed by Large and Very Large Companies7.4.2. Product Competitiveness Analysis: Coating Solutions7.4.2.1. Coating Solutions Developed by Very Small and Small Companies7.4.2.2. Coating Solutions Developed by Mid-sized Companies7.4.2.3. Coating Solutions Developed by Large and Very Large Companies8. MEDICAL DEVICE COATING PROVIDERS: COMPANY PROFILES8.1. Chapter Overview8.2. advanced coating8.2.1. Company Overview8.2.2. Recent Developments and Future Outlook8.3. Biocoat8.3.1. Company Overview8.3.2. Recent Developments and Future Outlook8.4. Evonik Health Care8.4.1. Company Overview8.4.2. Recent Developments and Future Outlook8.5. Formacoat8.5.1. Company Overview8.5.2. Recent Developments and Future Outlook8.6. Harland Medical Systems8.6.1. Company Overview8.6.2. Recent Developments and Future Outlook8.7. Para Coat Technologies8.7.1. Company Overview8.7.2. Recent Developments and Future Outlook8.8. Specialty Coating Systems8.8.1. Company Overview8.8.2. Recent Developments and Future Outlook8.9. SurModics8.9.1. Company Overview8.9.2. Recent Developments and Future Outlook8.10. TUA Systems8.10.1. Company Overview8.10.2. Recent Developments and Future Outlook9. PARTNERSHIPS AND COLLABORATIONS9.1. Chapter Overview9.2. Partnership Models9.3. List of Partnerships and Collaborations9.3.1. Analysis by Year of Partnership9.3.2. Analysis by Type of Partnership9.3.3. Analysis by Type of Partner9.3.4. Analysis by Geography9.3.5. Most Active Players: Analysis by Number of Partnerships10. MEDICAL DEVICE COATING PROVIDERS: PESTLE ANALYSIS10.1. Chapter Overview10.2. methodology 10.3. key factors10.3.1. political factors10.3.2. economic factors10.3.3. sociological factors10.3.4. Technological Factors10.3.5. Legal Factors10.3.6. environmental factors10.4. PESTLE Analysis: Medical Device Coating Providers10.4.1. Biocoat10.4.2. biomerics10.4.3. Diamond-MT10.4.4. Evonik Health Care10.4.5. Fisher Barton10.4.6. Formacoat10.4.7. Freudenberg10.4.8. Harland Medical Systems10.4.9. Master Bond10.4.10. materion10.4.11. N8 Medical10.4.12. Para Coat Technologies10.4.13. Specialty Coating Systems10.4.14. SurModics10.4.15. Tractivus10.5. Concluding Remarks11. MARKET FORECAST11.1. Chapter Overview11.2. Key Assumptions and Forecast Methodology11.3. Global Medical Device Coatings Market, 2023-203511.3.1. Global Medical Device Coatings Market: Distribution by Type of Medical Devices Coated, 2023 and 203511.3.1.1. Medical Device Coatings Market for Class I Devices, 2023-203511.3.1.2. Medical Device Coatings Market for Class II Devices, 2023-203511.3.1.3. Medical Device Coatings Market for Class III Devices, 2023-203511.3.2. Global Medical Device Coatings Market: Distribution by Type of Coating Material, 2023 and 203511.3.2.1. Medical Device Coatings Market for Polymer Coatings, 2023-203511.3.2.2. Medical Device Coatings Market for Metal Coatings, 2023-203511.3.2.3. Medical Device Coatings Market for Other Coatings, 2023-203511.3.3. Global Medical Device Coatings Market: Distribution by Company Size, 2023 and 203511.3.3.1. Medical Device Coatings Market for Very Small Companies, 2023-203511.3.3.2. Medical Device Coatings Market for Small Companies, 2023-203511.3.3.3. Medical Device Coatings Market for Mid-sized Companies, 2023-203511.3.3.4. Medical Device Coatings Market for Large Companies, 2023-203511.3.3.5. Medical Device Coatings Market for Very Large Companies, 2023-203511.3.4. Global Medical Device Coatings Market: Distribution by Key Geographical Regions, 2023 and 203511.3.4.1. Medical Device Coatings Market in North America, 2023-203511.3.4.2. Medical Device Coatings Market in Europe, 2023-203511.3.4.3. Medical Device Coatings Market in Asia, 2023-203511.3.4.4. Medical Device Coatings Market in the Rest of the World, 2023-203512 CONCLUDING REMARKS13 EXECUTIVE INSIGHTS13.1. Chapter Overview13.2. Biocoat13.2.1. Company Snapshot13.2.2. Interview Transcript: Mark Eberhardt, Senior Director of Marketing13.3. N8 Medical13.3.1. Company Snapshot13.3.2. Interview Transcript: Carl Genberg, Chief Scientific Officer13.4. Vaportech13.4.1. Company Snapshot13.4.2. Interview Transcript: David Wayne, Director of Sales and Marketing 14. APPENDIX 1: TABULATED DATA15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONSTo view more details on this report, click on the link :https://www.rootsanalysis.com/reports/medical-device-coatings-market.htmlYou may also be interested in the following titles:Cell Therapy Manufacturing MarketGlobal TCR Therapy MarketAbout Roots AnalysisRoots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.contact:Ben Johnson+1 (415) 800 3415 Ben.johnson@rootsanalysis.com#MedicalDeviceCoatingsmarket #MedicalDeviceCoatingsmarketGrowth #MedicalDeviceCoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies

• Нравится 0
• Комментировать 0
• 0

Пока нет комментариев

Pharmaceutical smart labels offer functionality and connectivity, along with providing an interactive and real-time solution, across the overall supply chainRoots Analysis has announced the addition of “Smart Pharmaceutical and Healthcare Labels Market, 2022-2035” report to its list of offerings. The report features an extensive study of the current market landscape and future opportunities associated with the smart pharmaceutical and healthcare labels, offering in-depth analyzes of the various business entities engaged in this domain, across key global regions.Request a free sample of the reporthttps://www.rootsanalysis.com/reports/smart-labels-market/request-sample.htmlAmongst other elements, the report includes:§A brief overview of smart labels, along with the information on their role and advantages in the healthcare sector, along with details on the types of smart labels, featuring their applications in the pharmaceutical and healthcare domain. In addition, it includes a discussion on various challenges associated with the adoption ofsmart labels, future perspectives, and the factors driving the smart pharmaceutical and healthcare labels industry.§A detailed review of the overall landscape of players engaged in the smart pharmaceutical and healthcare label providers domain, along with information on type of technology, RFID frequency band and area(s) of application.§A detailed competitiveness analysis of companies engaged in the development of smart pharmaceutical and healthcare labels , based on their supplier strength, service strength and portfolio strength.§Elaborate profiles of prominent players that claim to specialize in offering smart pharmaceutical and healthcare labels. Each profile features a brief overview of the company, along with information on their year of establishment, number of employees, location of headquarters, key executives, as well as details related to their smart labels focused portfolio, recent developments and an informed future outlook.§An in-depth analysis of patents related to smart pharmaceutical and healthcare labels that have been filed / granted till date, based on several relevant parameters, such as type of patent, publication year, geographical location / patent jurisdiction, legal status, CPC symbols , type of industry, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents filed / granted in this industry.§A detailed analysis of the partnerships and collaborations inked in the domain, during the period 2018-2022, based on several parameters, such as year of partnership, type of partnership, most active player and region.§A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market, featuring thirteen strategic tools that can help software developers to shift towards a blue ocean strategic market.§A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall smart pharmaceutical and healthcare labels market.§The financial opportunity within the smart labels market has been analyzed across the following segments: §Type of Technology§RFID§NFC§Other Technologies§Type of packaging§Primary Packaging§Secondary Packaging §Type of Primary Packaging§Vials§Syringes§Cartridges§Ampoules§Bottles§Blister Packs§Type of Secondary Packaging§Boxes§Cartons§Pouches§Key Geographical Regions§North America§Europe§Asia-Pacific§MENA§Latin AmericaTo view more details on this report, click on the link :https://www.rootsanalysis.com/reports/smart-labels-market.htmlYou may also be interested in the following titles:Cell Therapy Manufacturing MarketGlobal TCR Therapy MarketYou may also like to learn what our experts are sharing in Roots educational series:Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological IndicationsAbout Roots AnalysisRoots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.contact:Ben Johnson+1 (415) 800 3415 Ben.johnson@rootsanalysis.com#SmartLabelsMarket #SmartLabelsMarketGrowth #HealthcareLabels #SmartLabels #NFC

• Нравится 0
• Комментировать 0
• 0

Пока нет комментариев

As the six approved CAR-T cell therapies, including Breyanzi®, Abecma™ and CARVYKTI™ are poised to achieve blockbuster status, along with a promising development pipeline, the field of CAR-T cell therapies has gained significant tractionRoots Analysis is pleased to announce the publication of its recent study, titled, “ Global CAR-T Cell Therapy Market (4th Edition ), 2022-2035 .”The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:§A detailed assessment of the current market landscape of CAR-T-cell therapies.§An analysis of key insights derived from the study featuring a competitive analysis, highlighting the popular target antigens related to hematological malignancies and solid tumors.§A detailed analysis of completed, ongoing and planned clinical studies related to CAR-T cell therapies.§An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related toCAR-T cell therapies.§Elaborate profiles of marketed and mid- to late-stage clinical products (phase I/II or above).§An analysis of various type of partnership that have been inked between several stakeholders in the domain of CAR-T-cell therapies.§An analysis of the investments that have been made into companies that have proprietary CAR-T cell-based products / technologies.§An in-depth analysis of patents related to CAR-T cell therapies, filed / granted till 2022.§A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.§An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.§A review of the key promotional strategies being adopted by the developers of the approved CAR-T cell therapies.§Elaborate profiles of the several leading players in the domain of CAR-T cell therapies.A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):§Target Indication(s)§Non-Hodgkin's Lymphoma§Multiple Myeloma§Acute Lymphoblastic Leukemia§Chronic Lymphocytic Leukemia§Hodgkin's Lymphoma§Acute Myeloid Leukemia§Ovarian Cancer§Generalized Myasthenia Gravis (MG)§Renal Cell Carcinoma§Target Antigen§CD19§BCMA§CD19/22§Others§Key Geographical Regions§North America§Europe§Asia Pacific§Latin America§Middle East and North Africa§Rest of the WorldTranscripts of interviews held with the following senior level representatives of stakeholder companies: §Troels Jordansen (Chief Executive Officer, Glycostem Therapeutics)§Wei (William) Cao (Chief Executive Officer, Gracell Biotechnologies)§Miguel Forte (Chief Operating Officer, TxCell)§Adrian Bot (Vice President, Scientific Affairs, Kite Pharma)§Vincent Brichard (Vice President, Immuno-Oncology, Celyad)§Brian Dattilo (Manager of Business Development, Waisman Biomanufacturing)§Aino Kalervo (Former Competitive Intelligence Manager, Strategy & Business Development, Theravectys)§Xian-Bao Zhan (Professor of Medicine and Director, Department of Oncology, Changhai Hospital)§Enkhtsetseg Purev (Assistant Professor of Medicine, University of Colorado)The research includes profiles of key players ( listed below ); each profile features a brief overview of the company, details related to its financial information ( if available ), details about CAR-T-cell based product(s), such as information on type of therapy and current development status, information on technology portfolio ( if available ), recent developments related to CAR-T cell immunotherapies and manufacturing capabilities of the players. §AutolusBluebird Bio§Bristol Myers Squibb§Carsgen Therapeutics§Cellectis§Cellular Biomedicine Group§Gilead Sciences§Innovative Cellular Therapeutics§Kuur Therapeutics§Noile-Immune Biotech§Novartis§Shanghai GeneChem§Sinobioway Cell Therapy§Takara Bio§Wellington Zhaotai TherapiesGet more details on the CAR-T Cell Therapy Market report https://www.rootsanalysis.com/reports/view_document/car-t-therapies-market/269.htmlYou may also be interested in the following titles:DNA Encoded LibrariesQuantum Computing in Drug Discovery Services MarketYou may also like to learn what our experts are sharing in Roots educational series: mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule TIL Therapies: A New Paradigm in Cancer Treatment About Roots AnalysisRoots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.contact:Ben Johnson+1 (415) 800 3415Ben.johnson@rootsanalysis.com#CARTcelltherapyMarket #CARTcelltherapyMarket Size #CARTcellth0erapyMarketGrowth #CARTcelltherapies #ChimericAntigenReceptor

• Нравится 0
• Комментировать 0
• 0

Пока нет комментариев